Frequently Asked Questions Which medication causes more weight loss, tirzepatide or semaglutide
But it doesnt contain GLP-1, and it doesnt work the way a GLP-1 medication does
"We have a high obesity rate
However, evaluating COA authenticity and laboratory reputation requires understanding testing methodology beyond simply noting a certificate exists
There are now three GLP-1RA drugs approved in multiple countries [see Table 1] for chronic weight management, all of which are administered as injections: Wegovy (active substance semaglutide) and Saxenda (active substance liraglutide) from Novo Nordisk, and Mounjaro/Zepbound 1 (active substance tirzepatide) from Eli Lilly the latter being the first dual receptor agonist 2 drug approved
Both charts, next to each other, with all the context that makes the comparison meaningful